/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

K

Kristian Reich

Universität Hamburg(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

746

Papers

42.3K

Citations

104

h-index

389

i10-index

Kristian Reich is an academic researcher from Universität Hamburg. The author has contributed to research in topics: Psoriasis: Treatment and Pathogenesis & Dermatology and Skin Diseases & Autoimmune Bullous Skin Diseases. The author has an h-index of 104, co-authored 635 publications.

ORCID: 0000-0001-5248-4332

Research Topics

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Autoimmune Bullous Skin Diseases Asthma and respiratory diseases Pharmaceutical studies and practices

Papers by this author

works

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

2008 · The Lancet · 1,341 citations

https://doi.org/10.1016/s0140-6736(08)60726-6

Kim Papp Richard G. Langley Mark Lebwohl Gerald G. Krueger

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

2019 · Journal of the American Academy of Dermatology · 248 citations

https://doi.org/10.1016/j.jaad.2019.07.074

Mette Deleuran Diamant Thaçi Lisa A. Beck Marjolein de Bruin‐Weller

Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials

2011 · British Journal of Dermatology · 199 citations

https://doi.org/10.1111/j.1365-2133.2011.10583.x

Kristian Reich A. David Burden James Eaton Neil Hawkins

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

2020 · Journal of the American Academy of Dermatology · 165 citations

https://doi.org/10.1016/j.jaad.2020.04.104

Eric L. Simpson Robert Bissonnette Lawrence F. Eichenfield Emma Guttman‐Yassky

Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results

2021 · Journal of Allergy and Clinical Immunology · 119 citations

https://doi.org/10.1016/j.jaci.2021.07.036

Jonathan I. Silverberg Marjolein de Bruin‐Weller Thomas Bieber Weily Soong

Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials

2019 · Journal of the American Academy of Dermatology · 89 citations

https://doi.org/10.1016/j.jaad.2019.11.040

Kristian Reich C.E.M. Griffiths Kenneth B. Gordon Kim Papp

Research topics

topics

Psoriasis: Treatment and Pathogenesis

Dermatology and Skin Diseases

Autoimmune Bullous Skin Diseases

Asthma and respiratory diseases

Pharmaceutical studies and practices

Chat about Author

Papers

Chat

Click to start Chat